# Efficacy of an emotion-oriented cognitive behavior therapy for delusions (CBTd-E) compared to waitlist in a single-blinded randomized-controlled trial

**Authors:** Stephanie Mehl, Christopher Hautmann, Björn Schlier, Laura Marie-Louise Dorn, Lea Ludwig, Tobias Teismann, Michael Franz, Winfried Rief, Rudolf Stark, Tania Marie Lincoln

PMC · DOI: 10.1038/s41537-026-00737-y · Schizophrenia · 2026-02-17

## TL;DR

This study tested an emotion-focused therapy for delusions but found no significant improvement in delusions, though it helped with general mental health.

## Contribution

The study evaluated a novel emotion-oriented CBT variant targeting affect regulation and schemata for delusions in a randomized trial.

## Key findings

- CBTd-E showed no significant effect on delusions compared to a waitlist.
- CBTd-E improved general psychopathology and target mechanisms like cognitive reappraisal and self-esteem.
- No significant effects were found on positive/negative symptoms, depression, or functioning.

## Abstract

Psychological interventions for delusions may be enhanced by targeting their presumed causal factors. An emotion-oriented variant of cognitive behavioral therapy for delusions (CBTd-E), designed to target affect regulation and maladaptive schemata, was evaluated for its effect on delusions. A single-blind, multicenter, randomized, waitlist-controlled trial was conducted in three German outpatient clinics. Ninety-four patients with psychotic disorders and persistent delusions were randomized to 25 individual sessions of CBTd-E over 6 months (n = 47) or waitlist (n = 47). CBTd-E included two modules designed to improve affect regulation and maladaptive schemata. Assessments were performed at baseline (T1), three months (T2), and six months (T3). Regression-based analysis of covariance at T3 in the intent-to-treat sample indicated no significant benefit for the CBT-E group in the primary outcome (Psychotic Symptom Rating Scale delusions subscale, d = -0.45 [CI: 0.36; -1.26]). Regarding secondary outcomes, a significant effect favoring CBTd-E was observed in general psychopathology (d = -0.56), but no effects on positive and negative symptoms, depression, general and social functioning, or antipsychotic dosage. Regarding the proposed target mechanisms, we found improved cognitive reappraisal (d = 0.59), worrying (d = -0.52), quality of sleep (d = -0.49), and self-esteem (d = 0.36). Despite its effect on the suggested target mechanisms, affect regulation and maladaptive schemata, and on general psychopathology, this emotion-focused variant of CBT did not show an effect on delusions. A possible avenue to achieve stronger effects on delusions is to personalize the modularized interventions.

Trial registration: Clinicaltrials.gov Identifier: NCT02787135

## Full-text entities

- **Diseases:** delusions (MESH:D063726), psychotic disorders (MESH:D011618), depression (MESH:D003866)
- **Chemicals:** CBTd-E (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12992698/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12992698/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12992698/full.md

---
Source: https://tomesphere.com/paper/PMC12992698